Predictive Oncology Inc
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D cult… Read more
Predictive Oncology Inc (POAI) - Total Assets
Latest total assets as of September 2025: $3.14 Million USD
Based on the latest financial reports, Predictive Oncology Inc (POAI) holds total assets worth $3.14 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Predictive Oncology Inc - Total Assets Trend (2008–2024)
This chart illustrates how Predictive Oncology Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Predictive Oncology Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Predictive Oncology Inc's total assets of $3.14 Million consist of 44.8% current assets and 55.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.8% |
| Accounts Receivable | $745.57K | 15.0% |
| Inventory | $385.73K | 7.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $210.11K | 4.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Predictive Oncology Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Predictive Oncology Inc's current assets represent 44.8% of total assets in 2024, a decrease from 80.5% in 2008.
- Cash Position: Cash and equivalents constituted 14.8% of total assets in 2024, down from 58.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 18.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 15.0% of total assets.
Predictive Oncology Inc Competitors by Total Assets
Key competitors of Predictive Oncology Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Eastcompeace Technology Co Ltd
SHE:002017
|
China | CN¥2.97 Billion |
|
Wiscom System Co Ltd
SHE:002090
|
China | CN¥3.17 Billion |
|
Topsec Technologies Group Inc
SHE:002212
|
China | CN¥10.79 Billion |
|
Focus Technology Co Ltd
SHE:002315
|
China | CN¥4.27 Billion |
|
Beijing Venustech Inc
SHE:002439
|
China | CN¥13.16 Billion |
|
Maxvision Technology Corp
SHE:002990
|
China | CN¥3.74 Billion |
|
OpenSys M Bhd
KLSE:0040
|
Malaysia | RM129.25 Million |
|
Managepay Systems Bhd
KLSE:0156
|
Malaysia | RM86.24 Million |
Predictive Oncology Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Predictive Oncology Inc generates 0.33x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Predictive Oncology Inc is currently not profitable relative to its asset base.
Predictive Oncology Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 1.20 | 0.16 |
| Quick Ratio | 0.01 | 1.06 | 0.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-78.38 Million | $ 750.64K | $ -7.82 Million |
Predictive Oncology Inc - Advanced Valuation Insights
This section examines the relationship between Predictive Oncology Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.43 |
| Latest Market Cap to Assets Ratio | 2.02 |
| Asset Growth Rate (YoY) | -65.5% |
| Total Assets | $4.97 Million |
| Market Capitalization | $10.04 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Predictive Oncology Inc's assets at a significant premium ( 2.02x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Predictive Oncology Inc's assets decreased by 65.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Predictive Oncology Inc (2008–2024)
The table below shows the annual total assets of Predictive Oncology Inc from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.97 Million | -65.51% |
| 2023-12-31 | $14.42 Million | -43.98% |
| 2022-12-31 | $25.73 Million | -41.21% |
| 2021-12-31 | $43.77 Million | +235.14% |
| 2020-12-31 | $13.06 Million | -41.63% |
| 2019-12-31 | $22.38 Million | +503.28% |
| 2018-12-31 | $3.71 Million | +2.34% |
| 2017-12-31 | $3.62 Million | +29.09% |
| 2016-12-31 | $2.81 Million | -50.15% |
| 2015-12-31 | $5.63 Million | +525.15% |
| 2014-12-31 | $900.98K | +51.83% |
| 2013-12-31 | $593.43K | +60.57% |
| 2012-12-31 | $369.58K | -17.18% |
| 2011-12-31 | $446.22K | +169.01% |
| 2010-12-31 | $165.87K | -42.86% |
| 2009-12-31 | $290.30K | -63.21% |
| 2008-12-31 | $788.98K | -- |